BRCTF (BioArctic AB) Current Accrued Expense : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is BioArctic AB Current Accrued Expense?

BioArctic AB's Current Accrued Expense for the quarter that ended in Sep. 2024 was $0.00 Mil.

BioArctic AB Current Accrued Expense Historical Data

The historical data trend for BioArctic AB's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Current Accrued Expense Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

BioArctic AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

BioArctic AB Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

BioArctic AB Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OTCPK:BRCTF) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

BIOA B:Sweden BIOABs:UK 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.